Mutations in Tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-B regulation

Medicine & Life Sciences

• atrial natriuretic factor receptor B 100%
• C-Type Natriuretic Peptide 37%
• Mutation 33%
• sphingosine 1-phosphate 33%
• Heme 18%
• Phosphorylation 11%
• Threonine 9%
• Serine 8%
• Tyrosine 7%
• Nitric Oxide 6%
• Phosphotransferases 6%
• Membranes 5%

Chemical Compounds

• Mutation 50%
• C-Type Natriuretic Peptide 43%
• Sphingosine 1-Phosphate 37%
• Diuretic Agent 17%
• Threonine Residue 16%
• Tyrosine Residue 13%
• Nitric Oxide 11%
• Serine 11%